Deutsche Märkte öffnen in 5 Stunden 51 Minuten

Quotient Limited (QTNT)

NasdaqGM - NasdaqGM Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
0,8000-0,0686 (-7,90%)
Börsenschluss: 01:00PM EST
0,8351 +0,04 (+4,39%)
Nachbörse: 04:30PM EST

Quotient Limited

Business Park Terre Bonne
Route de Crassier 13
Eysins 1262
Switzerland
11 41 22 716 9800
https://www.quotientbd.com

Sektor(en)Healthcare
BrancheMedical Devices
Vollzeitmitarbeiter437

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Manuel O. MendezCEO & Director10,22MN/A1968
Mr. Ali KiboroChief Financial Officer798,9kN/A1975
Mr. Mohammad El KhouryChief Commercial Officer544,83kN/A1960
Ms. Vittoria BonassoHead of Fin., Group Controller & Principal Accounting OfficerN/AN/A1976
Dr. Michael HausmannChief Technology OfficerN/AN/AN/A
Dr. Christine GinocchioChief Scientific & Medical OfficerN/AN/AN/A
Ms. Viviane MontarnalHead of Legal Affairs & ComplianceN/AN/AN/A
Ms. Hyatt Antognini-AminHead of Corp. CommunicationsN/AN/AN/A
Mr. Christian AlbrichChief People OfficerN/AN/A1964
Mr. Esteban UriarteChief Manufacturing Operations OfficerN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company also offers MosaiQ SDS Microarray that is designed as a serological disease screening microarray comprised assays to detect cytomegalovirus and Syphilis; MosaiQ MDS Microarray that is designed as a molecular disease screening microarray test for donor red cells or source plasma; MosaiQ IH Microarray as a blood grouping microarray; MosaiQ Autoimmune Microarray; MosaiQ COVID-19; and MosaiQ IH3 Microarray. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.

Corporate Governance

Quotient Limiteds ISS Governance QualityScore, Stand 1. Oktober 2022, lautet 5. Die grundlegenden Scores sind Audit: 10, Vorstand: 4, Shareholderrechte: 3, Kompensation: 6.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.